Home » Newsletters » BioWorld Science

BioWorld Science

April 14, 2009

View Archived Issues

Novel piperidine derivatives claimed by Astellas Pharma

Novel anaplastic lymphoma kinase inhibitors claimed by IRM

Nitric oxide releasing derivatives of paracetamol patented

Bardoxolone methyl improves renal function in patients with chronic kidney disease

Novel antibacterial agents claimed by AstraZeneca

Novel protein kinase inhibitors described by IRM for the treatment of asthma

Atrial natriuretic peptide prevents contrast-induced nephropathy in patients with renal failure

Leflunomide acts as an immunosuppressant in kidney and/or pancreas transplant patients

Pre- and in-hospital initiation of tirofiban show similar benefits in myocardial infarction patients

Statin dose effect on HDL-cholesterol not uniform across agents

Dosing of anakinra in experimental myocardial infarction investigated

BioAlliance to complete NDA for Loramyc with new data

Donor lymphocyte infusion therapy increases post stem-cell transplantation survival rates

Results from a phase III study of Nuvigil in jet lag disorder announced by Cephalon

FDA Advisory Committee reviews Seroquel XR supplemental NDA

Merck & Co. and Cardiome sign license agreement for vernakalant for atrial fibrillation

Myriad receives IND approval for new cancer drug, MPC-3100

Nippon Shinyaku and Lilly enter agreement for new tadalafil indications

Othera reports interim phase II OT-551 results for dry AMD

Cell Therapeutics initiates rolling NDA for pixantrone

Prometheus and Rosetta Genomics enter license and collaboration agreement

Simponi approved for RA, psoriatic arthritis and ankylosing spondylitis

Aegis and Phylogica collaborate to deliver intranasal Phylomer peptide drugs

Celldex Therapeutics enhances immunotherapy platform

PAION and Ergomed report phase II data for CNS-5161 in neuropathic cancer pain

Ipsen provides update of FDA's review of its botulinum toxin type A product

Glenmark's molecule for neuropathic pain, GRC-10693, completes phase I trials

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.